Senior Associate
Noro-Moseley PartnersCheck size: $5M-$20M target investment range published by Noro-Moseley Partners; no person-specific range is disclosed.
Thomas Collier is part of Noro-Moseley Partners's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.
The firm publicly emphasizes invest early growth capital in rapidly scaling B2B technology and healthcare companies with strong economics, meaningful revenue, and limited prior funding.
No person-specific pass list is public. Opportunities outside the firm's published stage, sector, geography, or traction criteria appear less aligned.
Lead with founder-market fit, customer evidence, traction, the financing plan, and a precise explanation of alignment with the firm's published strategy.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Thomas Collier is Senior Associate at Noro-Moseley Partners, according to the firm's current official roster. To avoid mistaken identity, no unsupported prior employment, education, or portfolio attribution has been inferred.